SynthesisBMC cancer2021

Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.

Muhammad Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.